NEW: Earn CME for reading PulmCCM. We now partner with Learner , a reflective learning platform which lets you earn CME anywhere and anytime learning happens. open.substack.com/pub/pulmcc…
FDA approves a high-risk device with a <10% chance of success, and CMS agrees Medicare will pay $23,650 per patient for the device, all without requiring the marketer to show it’s superior to a plausible risk-free competitor that costs $75.
Can Lungpacer® wean your patient off the vent? pulmccm.org/p/can-lungpacer-…